Effects of Vildagliptine and Glimepiride on Glucose Variability
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to analyze the differences of blood sugar level and glycemic
variability between sulfonylurea and DPP-4 inhibitor groups applying CGMS for a chosen number
of type 2 DM patients. The investigators also reveal influences of each drugs on
cardiovascular risk factors by measuring related biomarkers.